0001566045-19-000004.txt : 20191105
0001566045-19-000004.hdr.sgml : 20191105
20191105144206
ACCESSION NUMBER: 0001566045-19-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191101
FILED AS OF DATE: 20191105
DATE AS OF CHANGE: 20191105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stanley Rhonda L.
CENTRAL INDEX KEY: 0001566045
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-13789
FILM NUMBER: 191192877
MAIL ADDRESS:
STREET 1: 5001 SOUTH MIAMA BOULEVARD
STREET 2: SUITE 300
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adhera Therapeutics, Inc.
CENTRAL INDEX KEY: 0000737207
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 112658569
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4721 EMPEROR BOULEVARD
STREET 2: SUITE 350
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-578-5901
MAIL ADDRESS:
STREET 1: 4721 EMPEROR BOULEVARD
STREET 2: SUITE 350
CITY: DURHAM
STATE: NC
ZIP: 27703
FORMER COMPANY:
FORMER CONFORMED NAME: Marina Biotech, Inc.
DATE OF NAME CHANGE: 20100722
FORMER COMPANY:
FORMER CONFORMED NAME: MDRNA, Inc.
DATE OF NAME CHANGE: 20080610
FORMER COMPANY:
FORMER CONFORMED NAME: NASTECH PHARMACEUTICAL CO INC
DATE OF NAME CHANGE: 19920703
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-11-01
0
0000737207
Adhera Therapeutics, Inc.
ATRX
0001566045
Stanley Rhonda L.
C/O ADHERA THERAPEUTICS, INC.
4721 EMPEROR BLVD., SUITE 350
DURHAM
NC
27703
0
1
0
0
SVP Finance & Accounting
Options to purchase common stock
0.09
2019-11-01
4
A
0
350000
0
A
2029-11-01
common stock
350000
350000
D
Options to purchase 75,000 shares are exercisable immediately, options to purchase 75,000 shares shall vest on each of November 1, 2020, November 1, 2021 and November 1, 2022, options to purchase 25,000 shares shall vest on such date (if any) that the Issuer determines that the "Revenue Target" (as defined in the Employment Agreement dated October 29, 2019 between the Issuer and the reporting person (the "Employment Agreement")) is achieved, and options to purchase 25,000 shares shall vest on such date (if any) that the Issuer determines that the "Stock Price Target" (as defined in the Employment Agreement) has been achieved.
/s/ Rhonda Stanley
2019-11-05